Suppr超能文献

长效甲状腺刺激素和长效甲状腺刺激素保护剂均可刺激人体甲状腺的证据。

Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.

作者信息

Holmes S D, Dirmikis S M, Martin T J, Munro D S

出版信息

J Endocrinol. 1979 Feb;80(2):215-21. doi: 10.1677/joe.0.0800215.

Abstract

Thyroid-stimulating immunoglobulins were prepared from two potent sera, one contained long-acting thyroid stimulator (LATS) and the other contained both LATS and LATS-protector (LATS-P). The potencies of the immunoglobulin G (IgG) preparations were estimated in the McKenzie assay. The accumulation of cyclic AMP in mouse thyroid lobes was stimulated only by LATS--IgG; LATS-P--IgG was inactive. In contrast, both LATS-IgG and LATS-P--IgG were equally effective in slices of human thyroid.

摘要

从两份高效血清中制备了促甲状腺免疫球蛋白,一份含有长效甲状腺刺激素(LATS),另一份同时含有LATS和LATS保护物(LATS-P)。采用麦肯齐试验评估了免疫球蛋白G(IgG)制剂的效价。仅LATS-IgG能刺激小鼠甲状腺叶中环状AMP的积累;LATS-P-IgG无活性。相比之下,LATS-IgG和LATS-P-IgG在人甲状腺切片中同样有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验